{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:22Z","timestamp":1792788502029,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007\/2013"],"award-info":[{"award-number":["FP7\/2007\/2013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clim.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T11:02:20Z","timestamp":1495105340000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Decrease of blood anti-\u03b11,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients"],"prefix":"10.1016","volume":"180","author":[{"given":"L.","family":"Le Berre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-A.","family":"Gourraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-M.","family":"Imbert-Marcille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Evanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Semana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dugast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gu\u00e9rif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Adjaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Freour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Brouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Agbalika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Brassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-A.","family":"Laplaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Van Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Soulillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.05.006_bb0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up?","volume":"13","author":"Stys","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clim.2017.05.006_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.clim.2017.05.006_bb0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Hafler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/WCO.0b013e3283533a93","article-title":"Genetics of multiple sclerosis: swimming in an ocean of data","volume":"25","author":"Baranzini","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clim.2017.05.006_bb0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/1073858410386615","article-title":"Viruses and multiple sclerosis","volume":"17","author":"Owens","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clim.2017.05.006_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clim.2017.05.006_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.it.2009.03.007","article-title":"EBV in MS: guilty by association?","volume":"30","author":"L\u00fcnemann","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMcibr035136","article-title":"Molecular mimicry in multiple sclerosis","volume":"349","author":"Wekerle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","article-title":"Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis","volume":"230","author":"Casiraghi","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0050","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"TEmporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2017.05.006_bb0055","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2017.05.006_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated EBNA1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"L\u00fcnemann","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2017.05.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clim.2017.05.006_bb0070","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.clim.2017.05.006_bb0075","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/01.wnl.0000247663.40297.2d","article-title":"Multiple sclerosis and the hygiene hypothesis","volume":"67","author":"Fleming","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2017.05.006_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12016-011-8285-8","article-title":"Hygiene hypothesis and autoimmune diseases","volume":"42","author":"Rook","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mehy.2013.01.036","article-title":"Missing links in multiple sclerosis etiology. A working connecting hypothesis","volume":"80","author":"Soulillou","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.clim.2017.05.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01651349","article-title":"Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test","volume":"11","author":"Burgio","year":"1983","journal-title":"Infection"},{"key":"10.1016\/j.clim.2017.05.006_bb0095","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.18388\/abp.2003_3644","article-title":"Paul-Bunnell antigen and a possible mechanism of formation of heterophile antibodies in patients with infectious mononucleosis","volume":"50","author":"Go\u0142aszewska","year":"2003","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.clim.2017.05.006_bb0100","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.129.6.2524","article-title":"Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases","volume":"129","author":"Morito","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T Cells during the primary immune response to Epstein-Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04446.x","article-title":"Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein\u2013Barr virus entry to the central nervous system?","volume":"167","author":"Meier","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0115","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","article-title":"Acute Infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-Cell compartment with resting, latently infected cells","volume":"78","author":"Hochberg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2017.05.006_bb0120","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1182\/blood-2009-05-220400","article-title":"Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium","volume":"114","author":"Pham","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.05.006_bb0125","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI82267","article-title":"Rabbit antithymocyte globulin\u2013induced serum sickness disease and human kidney graft survival","volume":"125","author":"Couvrat-Desvergnes","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.05.006_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/xen.12142","article-title":"Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation","volume":"22","author":"Salama","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.clim.2017.05.006_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1474-4422(05)70095-8","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2017.05.006_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2017.05.006_bb0145","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/1352458513488232","article-title":"Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis","volume":"19","author":"Teunissen","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.clim.2017.05.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058443","article-title":"A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease","volume":"8","author":"Padler-Karavani","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clim.2017.05.006_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1399-3089.1999.00023.x","article-title":"Quantitation and characterization of anti-Gal\u03b11\u20133Gal antibodies in sera of 200 healthy persons","volume":"6","author":"Buonomano","year":"1999","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.clim.2017.05.006_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00201098","article-title":"Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody","volume":"15","author":"Galili","year":"1993","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.clim.2017.05.006_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevOncog.v6.i3-6.70","article-title":"Structure and pathophysiology of the erythrocyte membrane-associated Paul-Bunnell heterophile antibody determinant in Epstein-Barr virus-associated disease","volume":"6","author":"Patarca","year":"1995","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.clim.2017.05.006_bb0170","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.2131556100","article-title":"Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid","volume":"100","author":"Tangvoranuntakul","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.05.006_bb0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/tid.12006","article-title":"Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients","volume":"14","author":"Fairhead","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.clim.2017.05.006_bb0180","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-hla antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.clim.2017.05.006_bb0185","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/TP.0b013e3181ca56f8","article-title":"Effects of influenza immunization on humoral and cellular alloreactivity in humans","volume":"89","author":"Danziger-Isakov","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2017.05.006_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12110","article-title":"Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits","volume":"140","author":"Galili","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2017.05.006_bb0195","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20100575","article-title":"Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid","volume":"207","author":"Taylor","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0200","first-page":"39","article-title":"Epstein-Barr virus and MS: causality or association?","volume":"17","author":"Ludwin","year":"2011","journal-title":"Int. MS J. MS Forum."},{"key":"10.1016\/j.clim.2017.05.006_bb0205","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-\u03b1-1,3-Galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pt.2015.06.016","article-title":"Regulation of the immune response to \u03b1-Gal and vector-borne diseases","volume":"31","author":"Cabezas-Cruz","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.clim.2017.05.006_bb0215","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cell.2014.10.053","article-title":"Gut microbiota elicits a protective immune response against malaria transmission","volume":"159","author":"Yilmaz","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.clim.2017.05.006_bb0220","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.4049\/jimmunol.142.8.2828","article-title":"Immunogenic Gal alpha 1\u20143Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania","volume":"142","author":"Avila","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1084\/jem.166.2.419","article-title":"Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes","volume":"166","author":"Towbin","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.05.006_bb0230","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/art.1780331206","article-title":"Yersinia enterocolitica In the synovial membrane of patients with Yersinia-induced Arthritis","volume":"33","author":"Hammer","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.05.006_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/379085a0","article-title":"Sensitization of cells and retroviruses to human serum by (\u03b1l-3) galactosyltransferase","volume":"379","author":"Takeuchi","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.05.006_bb0240","first-page":"339","article-title":"Graves disease as a model for anti-Gal involvement in autoimmune diseases","volume":"32","author":"Galili","year":"1999","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.clim.2017.05.006_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/acta.0.1150067","article-title":"Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy?","volume":"115","author":"Etienne-Decerf","year":"1987","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.clim.2017.05.006_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3430125","article-title":"An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system","volume":"343","author":"Mosedale","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2017.05.006_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jim.2005.12.003","article-title":"A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis","volume":"309","author":"Mosedale","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2017.05.006_bb0260","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.05.006_bb0265","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.clim.2017.05.006_bb0270","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.05.006_bb0275","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.1601438","article-title":"Influence of the gut microbiome on autoimmunity in the central nervous system","volume":"198","author":"Colpitts","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.05.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2017.05.006_bb0285","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2017.05.006_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:41:16Z","timestamp":1692808876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616306362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":58,"alternative-id":["S1521661616306362"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.05.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decrease of blood anti-\u03b11,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}